Global Adeno Associated Virus Gene Therapy Market Research Report 2025(Status and Outlook)
The global Adeno Associated Virus Gene Therapy market size was estimated at USD 1717.22 million in 2024 and is projected to grow at a compound annual growth rate (CAGR) of 7.50% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Adeno Associated Virus Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Adeno Associated Virus Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Adeno Associated Virus Gene Therapy market.
Global Adeno Associated Virus Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., Ltd.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
Market Segmentation (by Type)
Gene Silencing
Gene Replacement
Gene Addition
Gene Editing
Market Segmentation (by Application)
Hospitals
Research Institute
Others
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Adeno Associated Virus Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Adeno Associated Virus Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Adeno Associated Virus Gene Therapy market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Adeno Associated Virus Gene Therapy market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Adeno Associated Virus Gene Therapy market.
Global Adeno Associated Virus Gene Therapy Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Creative Biolabs
Affinia Therapeutics
Spark Therapeutics
AGC Biologics
StrideBio
SIRION Biotech
Neurophth Biotechnology
Belief BioMed
BiBo Biopharma Engineering Co., Ltd.
Beihai Kangcheng
PackGene Biotech
Sarepta Therapeutics
Carbon BioSciences
Kelonia Therapeutics
Roche
Remedium Bio
Market Segmentation (by Type)
Gene Silencing
Gene Replacement
Gene Addition
Gene Editing
Market Segmentation (by Application)
Hospitals
Research Institute
Others
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Adeno Associated Virus Gene Therapy Market
- Overview of the regional outlook of the Adeno Associated Virus Gene Therapy Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Adeno Associated Virus Gene Therapy Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Adeno Associated Virus Gene Therapy, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Adeno Associated Virus Gene Therapy
1.2 Key Market Segments
1.2.1 Adeno Associated Virus Gene Therapy Segment by Type
1.2.2 Adeno Associated Virus Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Adeno Associated Virus Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Adeno Associated Virus Gene Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Adeno Associated Virus Gene Therapy Product Life Cycle
3.3 Global Adeno Associated Virus Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Adeno Associated Virus Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Adeno Associated Virus Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Adeno Associated Virus Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Adeno Associated Virus Gene Therapy Market Competitive Situation and Trends
3.8.1 Adeno Associated Virus Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Adeno Associated Virus Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ADENO ASSOCIATED VIRUS GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Adeno Associated Virus Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ADENO ASSOCIATED VIRUS GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Adeno Associated Virus Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Adeno Associated Virus Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adeno Associated Virus Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Adeno Associated Virus Gene Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Adeno Associated Virus Gene Therapy Price by Type (2020-2025)
7 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adeno Associated Virus Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Adeno Associated Virus Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Adeno Associated Virus Gene Therapy Sales Growth Rate by Application (2020-2025)
8 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET SALES BY REGION
8.1 Global Adeno Associated Virus Gene Therapy Sales by Region
8.1.1 Global Adeno Associated Virus Gene Therapy Sales by Region
8.1.2 Global Adeno Associated Virus Gene Therapy Sales Market Share by Region
8.2 Global Adeno Associated Virus Gene Therapy Market Size by Region
8.2.1 Global Adeno Associated Virus Gene Therapy Market Size by Region
8.2.2 Global Adeno Associated Virus Gene Therapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Adeno Associated Virus Gene Therapy Sales by Country
8.3.2 North America Adeno Associated Virus Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Adeno Associated Virus Gene Therapy Sales by Country
8.4.2 Europe Adeno Associated Virus Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Adeno Associated Virus Gene Therapy Sales by Region
8.5.2 Asia Pacific Adeno Associated Virus Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Adeno Associated Virus Gene Therapy Sales by Country
8.6.2 South America Adeno Associated Virus Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Adeno Associated Virus Gene Therapy Sales by Region
8.7.2 Middle East and Africa Adeno Associated Virus Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Adeno Associated Virus Gene Therapy by Region(2020-2025)
9.2 Global Adeno Associated Virus Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Adeno Associated Virus Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Adeno Associated Virus Gene Therapy Production
9.4.1 North America Adeno Associated Virus Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Adeno Associated Virus Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Adeno Associated Virus Gene Therapy Production
9.5.1 Europe Adeno Associated Virus Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Adeno Associated Virus Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Adeno Associated Virus Gene Therapy Production (2020-2025)
9.6.1 Japan Adeno Associated Virus Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Adeno Associated Virus Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Adeno Associated Virus Gene Therapy Production (2020-2025)
9.7.1 China Adeno Associated Virus Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Adeno Associated Virus Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Creative Biolabs
10.1.1 Creative Biolabs Basic Information
10.1.2 Creative Biolabs Adeno Associated Virus Gene Therapy Product Overview
10.1.3 Creative Biolabs Adeno Associated Virus Gene Therapy Product Market Performance
10.1.4 Creative Biolabs Business Overview
10.1.5 Creative Biolabs SWOT Analysis
10.1.6 Creative Biolabs Recent Developments
10.2 Affinia Therapeutics
10.2.1 Affinia Therapeutics Basic Information
10.2.2 Affinia Therapeutics Adeno Associated Virus Gene Therapy Product Overview
10.2.3 Affinia Therapeutics Adeno Associated Virus Gene Therapy Product Market Performance
10.2.4 Affinia Therapeutics Business Overview
10.2.5 Affinia Therapeutics SWOT Analysis
10.2.6 Affinia Therapeutics Recent Developments
10.3 Spark Therapeutics
10.3.1 Spark Therapeutics Basic Information
10.3.2 Spark Therapeutics Adeno Associated Virus Gene Therapy Product Overview
10.3.3 Spark Therapeutics Adeno Associated Virus Gene Therapy Product Market Performance
10.3.4 Spark Therapeutics Business Overview
10.3.5 Spark Therapeutics SWOT Analysis
10.3.6 Spark Therapeutics Recent Developments
10.4 AGC Biologics
10.4.1 AGC Biologics Basic Information
10.4.2 AGC Biologics Adeno Associated Virus Gene Therapy Product Overview
10.4.3 AGC Biologics Adeno Associated Virus Gene Therapy Product Market Performance
10.4.4 AGC Biologics Business Overview
10.4.5 AGC Biologics Recent Developments
10.5 StrideBio
10.5.1 StrideBio Basic Information
10.5.2 StrideBio Adeno Associated Virus Gene Therapy Product Overview
10.5.3 StrideBio Adeno Associated Virus Gene Therapy Product Market Performance
10.5.4 StrideBio Business Overview
10.5.5 StrideBio Recent Developments
10.6 SIRION Biotech
10.6.1 SIRION Biotech Basic Information
10.6.2 SIRION Biotech Adeno Associated Virus Gene Therapy Product Overview
10.6.3 SIRION Biotech Adeno Associated Virus Gene Therapy Product Market Performance
10.6.4 SIRION Biotech Business Overview
10.6.5 SIRION Biotech Recent Developments
10.7 Neurophth Biotechnology
10.7.1 Neurophth Biotechnology Basic Information
10.7.2 Neurophth Biotechnology Adeno Associated Virus Gene Therapy Product Overview
10.7.3 Neurophth Biotechnology Adeno Associated Virus Gene Therapy Product Market Performance
10.7.4 Neurophth Biotechnology Business Overview
10.7.5 Neurophth Biotechnology Recent Developments
10.8 Belief BioMed
10.8.1 Belief BioMed Basic Information
10.8.2 Belief BioMed Adeno Associated Virus Gene Therapy Product Overview
10.8.3 Belief BioMed Adeno Associated Virus Gene Therapy Product Market Performance
10.8.4 Belief BioMed Business Overview
10.8.5 Belief BioMed Recent Developments
10.9 BiBo Biopharma Engineering Co., Ltd.
10.9.1 BiBo Biopharma Engineering Co., Ltd. Basic Information
10.9.2 BiBo Biopharma Engineering Co., Ltd. Adeno Associated Virus Gene Therapy Product Overview
10.9.3 BiBo Biopharma Engineering Co., Ltd. Adeno Associated Virus Gene Therapy Product Market Performance
10.9.4 BiBo Biopharma Engineering Co., Ltd. Business Overview
10.9.5 BiBo Biopharma Engineering Co., Ltd. Recent Developments
10.10 Beihai Kangcheng
10.10.1 Beihai Kangcheng Basic Information
10.10.2 Beihai Kangcheng Adeno Associated Virus Gene Therapy Product Overview
10.10.3 Beihai Kangcheng Adeno Associated Virus Gene Therapy Product Market Performance
10.10.4 Beihai Kangcheng Business Overview
10.10.5 Beihai Kangcheng Recent Developments
10.11 PackGene Biotech
10.11.1 PackGene Biotech Basic Information
10.11.2 PackGene Biotech Adeno Associated Virus Gene Therapy Product Overview
10.11.3 PackGene Biotech Adeno Associated Virus Gene Therapy Product Market Performance
10.11.4 PackGene Biotech Business Overview
10.11.5 PackGene Biotech Recent Developments
10.12 Sarepta Therapeutics
10.12.1 Sarepta Therapeutics Basic Information
10.12.2 Sarepta Therapeutics Adeno Associated Virus Gene Therapy Product Overview
10.12.3 Sarepta Therapeutics Adeno Associated Virus Gene Therapy Product Market Performance
10.12.4 Sarepta Therapeutics Business Overview
10.12.5 Sarepta Therapeutics Recent Developments
10.13 Carbon BioSciences
10.13.1 Carbon BioSciences Basic Information
10.13.2 Carbon BioSciences Adeno Associated Virus Gene Therapy Product Overview
10.13.3 Carbon BioSciences Adeno Associated Virus Gene Therapy Product Market Performance
10.13.4 Carbon BioSciences Business Overview
10.13.5 Carbon BioSciences Recent Developments
10.14 Kelonia Therapeutics
10.14.1 Kelonia Therapeutics Basic Information
10.14.2 Kelonia Therapeutics Adeno Associated Virus Gene Therapy Product Overview
10.14.3 Kelonia Therapeutics Adeno Associated Virus Gene Therapy Product Market Performance
10.14.4 Kelonia Therapeutics Business Overview
10.14.5 Kelonia Therapeutics Recent Developments
10.15 Roche
10.15.1 Roche Basic Information
10.15.2 Roche Adeno Associated Virus Gene Therapy Product Overview
10.15.3 Roche Adeno Associated Virus Gene Therapy Product Market Performance
10.15.4 Roche Business Overview
10.15.5 Roche Recent Developments
10.16 Remedium Bio
10.16.1 Remedium Bio Basic Information
10.16.2 Remedium Bio Adeno Associated Virus Gene Therapy Product Overview
10.16.3 Remedium Bio Adeno Associated Virus Gene Therapy Product Market Performance
10.16.4 Remedium Bio Business Overview
10.16.5 Remedium Bio Recent Developments
11 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Adeno Associated Virus Gene Therapy Market Size Forecast
11.2 Global Adeno Associated Virus Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Adeno Associated Virus Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Adeno Associated Virus Gene Therapy Market Size Forecast by Region
11.2.4 South America Adeno Associated Virus Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Adeno Associated Virus Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Adeno Associated Virus Gene Therapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Adeno Associated Virus Gene Therapy by Type (2026-2033)
12.1.2 Global Adeno Associated Virus Gene Therapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Adeno Associated Virus Gene Therapy by Type (2026-2033)
12.2 Global Adeno Associated Virus Gene Therapy Market Forecast by Application (2026-2033)
12.2.1 Global Adeno Associated Virus Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Adeno Associated Virus Gene Therapy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Adeno Associated Virus Gene Therapy
1.2 Key Market Segments
1.2.1 Adeno Associated Virus Gene Therapy Segment by Type
1.2.2 Adeno Associated Virus Gene Therapy Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Adeno Associated Virus Gene Therapy Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Adeno Associated Virus Gene Therapy Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Adeno Associated Virus Gene Therapy Product Life Cycle
3.3 Global Adeno Associated Virus Gene Therapy Sales by Manufacturers (2020-2025)
3.4 Global Adeno Associated Virus Gene Therapy Revenue Market Share by Manufacturers (2020-2025)
3.5 Adeno Associated Virus Gene Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Adeno Associated Virus Gene Therapy Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Adeno Associated Virus Gene Therapy Market Competitive Situation and Trends
3.8.1 Adeno Associated Virus Gene Therapy Market Concentration Rate
3.8.2 Global 5 and 10 Largest Adeno Associated Virus Gene Therapy Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 ADENO ASSOCIATED VIRUS GENE THERAPY INDUSTRY CHAIN ANALYSIS
4.1 Adeno Associated Virus Gene Therapy Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF ADENO ASSOCIATED VIRUS GENE THERAPY MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Adeno Associated Virus Gene Therapy Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Adeno Associated Virus Gene Therapy Market
5.7 ESG Ratings of Leading Companies
6 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Adeno Associated Virus Gene Therapy Sales Market Share by Type (2020-2025)
6.3 Global Adeno Associated Virus Gene Therapy Market Size Market Share by Type (2020-2025)
6.4 Global Adeno Associated Virus Gene Therapy Price by Type (2020-2025)
7 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Adeno Associated Virus Gene Therapy Market Sales by Application (2020-2025)
7.3 Global Adeno Associated Virus Gene Therapy Market Size (M USD) by Application (2020-2025)
7.4 Global Adeno Associated Virus Gene Therapy Sales Growth Rate by Application (2020-2025)
8 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET SALES BY REGION
8.1 Global Adeno Associated Virus Gene Therapy Sales by Region
8.1.1 Global Adeno Associated Virus Gene Therapy Sales by Region
8.1.2 Global Adeno Associated Virus Gene Therapy Sales Market Share by Region
8.2 Global Adeno Associated Virus Gene Therapy Market Size by Region
8.2.1 Global Adeno Associated Virus Gene Therapy Market Size by Region
8.2.2 Global Adeno Associated Virus Gene Therapy Market Size Market Share by Region
8.3 North America
8.3.1 North America Adeno Associated Virus Gene Therapy Sales by Country
8.3.2 North America Adeno Associated Virus Gene Therapy Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Adeno Associated Virus Gene Therapy Sales by Country
8.4.2 Europe Adeno Associated Virus Gene Therapy Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Adeno Associated Virus Gene Therapy Sales by Region
8.5.2 Asia Pacific Adeno Associated Virus Gene Therapy Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Adeno Associated Virus Gene Therapy Sales by Country
8.6.2 South America Adeno Associated Virus Gene Therapy Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Adeno Associated Virus Gene Therapy Sales by Region
8.7.2 Middle East and Africa Adeno Associated Virus Gene Therapy Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET PRODUCTION BY REGION
9.1 Global Production of Adeno Associated Virus Gene Therapy by Region(2020-2025)
9.2 Global Adeno Associated Virus Gene Therapy Revenue Market Share by Region (2020-2025)
9.3 Global Adeno Associated Virus Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Adeno Associated Virus Gene Therapy Production
9.4.1 North America Adeno Associated Virus Gene Therapy Production Growth Rate (2020-2025)
9.4.2 North America Adeno Associated Virus Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Adeno Associated Virus Gene Therapy Production
9.5.1 Europe Adeno Associated Virus Gene Therapy Production Growth Rate (2020-2025)
9.5.2 Europe Adeno Associated Virus Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Adeno Associated Virus Gene Therapy Production (2020-2025)
9.6.1 Japan Adeno Associated Virus Gene Therapy Production Growth Rate (2020-2025)
9.6.2 Japan Adeno Associated Virus Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Adeno Associated Virus Gene Therapy Production (2020-2025)
9.7.1 China Adeno Associated Virus Gene Therapy Production Growth Rate (2020-2025)
9.7.2 China Adeno Associated Virus Gene Therapy Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Creative Biolabs
10.1.1 Creative Biolabs Basic Information
10.1.2 Creative Biolabs Adeno Associated Virus Gene Therapy Product Overview
10.1.3 Creative Biolabs Adeno Associated Virus Gene Therapy Product Market Performance
10.1.4 Creative Biolabs Business Overview
10.1.5 Creative Biolabs SWOT Analysis
10.1.6 Creative Biolabs Recent Developments
10.2 Affinia Therapeutics
10.2.1 Affinia Therapeutics Basic Information
10.2.2 Affinia Therapeutics Adeno Associated Virus Gene Therapy Product Overview
10.2.3 Affinia Therapeutics Adeno Associated Virus Gene Therapy Product Market Performance
10.2.4 Affinia Therapeutics Business Overview
10.2.5 Affinia Therapeutics SWOT Analysis
10.2.6 Affinia Therapeutics Recent Developments
10.3 Spark Therapeutics
10.3.1 Spark Therapeutics Basic Information
10.3.2 Spark Therapeutics Adeno Associated Virus Gene Therapy Product Overview
10.3.3 Spark Therapeutics Adeno Associated Virus Gene Therapy Product Market Performance
10.3.4 Spark Therapeutics Business Overview
10.3.5 Spark Therapeutics SWOT Analysis
10.3.6 Spark Therapeutics Recent Developments
10.4 AGC Biologics
10.4.1 AGC Biologics Basic Information
10.4.2 AGC Biologics Adeno Associated Virus Gene Therapy Product Overview
10.4.3 AGC Biologics Adeno Associated Virus Gene Therapy Product Market Performance
10.4.4 AGC Biologics Business Overview
10.4.5 AGC Biologics Recent Developments
10.5 StrideBio
10.5.1 StrideBio Basic Information
10.5.2 StrideBio Adeno Associated Virus Gene Therapy Product Overview
10.5.3 StrideBio Adeno Associated Virus Gene Therapy Product Market Performance
10.5.4 StrideBio Business Overview
10.5.5 StrideBio Recent Developments
10.6 SIRION Biotech
10.6.1 SIRION Biotech Basic Information
10.6.2 SIRION Biotech Adeno Associated Virus Gene Therapy Product Overview
10.6.3 SIRION Biotech Adeno Associated Virus Gene Therapy Product Market Performance
10.6.4 SIRION Biotech Business Overview
10.6.5 SIRION Biotech Recent Developments
10.7 Neurophth Biotechnology
10.7.1 Neurophth Biotechnology Basic Information
10.7.2 Neurophth Biotechnology Adeno Associated Virus Gene Therapy Product Overview
10.7.3 Neurophth Biotechnology Adeno Associated Virus Gene Therapy Product Market Performance
10.7.4 Neurophth Biotechnology Business Overview
10.7.5 Neurophth Biotechnology Recent Developments
10.8 Belief BioMed
10.8.1 Belief BioMed Basic Information
10.8.2 Belief BioMed Adeno Associated Virus Gene Therapy Product Overview
10.8.3 Belief BioMed Adeno Associated Virus Gene Therapy Product Market Performance
10.8.4 Belief BioMed Business Overview
10.8.5 Belief BioMed Recent Developments
10.9 BiBo Biopharma Engineering Co., Ltd.
10.9.1 BiBo Biopharma Engineering Co., Ltd. Basic Information
10.9.2 BiBo Biopharma Engineering Co., Ltd. Adeno Associated Virus Gene Therapy Product Overview
10.9.3 BiBo Biopharma Engineering Co., Ltd. Adeno Associated Virus Gene Therapy Product Market Performance
10.9.4 BiBo Biopharma Engineering Co., Ltd. Business Overview
10.9.5 BiBo Biopharma Engineering Co., Ltd. Recent Developments
10.10 Beihai Kangcheng
10.10.1 Beihai Kangcheng Basic Information
10.10.2 Beihai Kangcheng Adeno Associated Virus Gene Therapy Product Overview
10.10.3 Beihai Kangcheng Adeno Associated Virus Gene Therapy Product Market Performance
10.10.4 Beihai Kangcheng Business Overview
10.10.5 Beihai Kangcheng Recent Developments
10.11 PackGene Biotech
10.11.1 PackGene Biotech Basic Information
10.11.2 PackGene Biotech Adeno Associated Virus Gene Therapy Product Overview
10.11.3 PackGene Biotech Adeno Associated Virus Gene Therapy Product Market Performance
10.11.4 PackGene Biotech Business Overview
10.11.5 PackGene Biotech Recent Developments
10.12 Sarepta Therapeutics
10.12.1 Sarepta Therapeutics Basic Information
10.12.2 Sarepta Therapeutics Adeno Associated Virus Gene Therapy Product Overview
10.12.3 Sarepta Therapeutics Adeno Associated Virus Gene Therapy Product Market Performance
10.12.4 Sarepta Therapeutics Business Overview
10.12.5 Sarepta Therapeutics Recent Developments
10.13 Carbon BioSciences
10.13.1 Carbon BioSciences Basic Information
10.13.2 Carbon BioSciences Adeno Associated Virus Gene Therapy Product Overview
10.13.3 Carbon BioSciences Adeno Associated Virus Gene Therapy Product Market Performance
10.13.4 Carbon BioSciences Business Overview
10.13.5 Carbon BioSciences Recent Developments
10.14 Kelonia Therapeutics
10.14.1 Kelonia Therapeutics Basic Information
10.14.2 Kelonia Therapeutics Adeno Associated Virus Gene Therapy Product Overview
10.14.3 Kelonia Therapeutics Adeno Associated Virus Gene Therapy Product Market Performance
10.14.4 Kelonia Therapeutics Business Overview
10.14.5 Kelonia Therapeutics Recent Developments
10.15 Roche
10.15.1 Roche Basic Information
10.15.2 Roche Adeno Associated Virus Gene Therapy Product Overview
10.15.3 Roche Adeno Associated Virus Gene Therapy Product Market Performance
10.15.4 Roche Business Overview
10.15.5 Roche Recent Developments
10.16 Remedium Bio
10.16.1 Remedium Bio Basic Information
10.16.2 Remedium Bio Adeno Associated Virus Gene Therapy Product Overview
10.16.3 Remedium Bio Adeno Associated Virus Gene Therapy Product Market Performance
10.16.4 Remedium Bio Business Overview
10.16.5 Remedium Bio Recent Developments
11 ADENO ASSOCIATED VIRUS GENE THERAPY MARKET FORECAST BY REGION
11.1 Global Adeno Associated Virus Gene Therapy Market Size Forecast
11.2 Global Adeno Associated Virus Gene Therapy Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Adeno Associated Virus Gene Therapy Market Size Forecast by Country
11.2.3 Asia Pacific Adeno Associated Virus Gene Therapy Market Size Forecast by Region
11.2.4 South America Adeno Associated Virus Gene Therapy Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Adeno Associated Virus Gene Therapy by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Adeno Associated Virus Gene Therapy Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Adeno Associated Virus Gene Therapy by Type (2026-2033)
12.1.2 Global Adeno Associated Virus Gene Therapy Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Adeno Associated Virus Gene Therapy by Type (2026-2033)
12.2 Global Adeno Associated Virus Gene Therapy Market Forecast by Application (2026-2033)
12.2.1 Global Adeno Associated Virus Gene Therapy Sales (K Units) Forecast by Application
12.2.2 Global Adeno Associated Virus Gene Therapy Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adeno Associated Virus Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Adeno Associated Virus Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Adeno Associated Virus Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Adeno Associated Virus Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Adeno Associated Virus Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno Associated Virus Gene Therapy as of 2024)
Table 10. Global Market Adeno Associated Virus Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Adeno Associated Virus Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Adeno Associated Virus Gene Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Adeno Associated Virus Gene Therapy Sales by Type (K Units)
Table 26. Global Adeno Associated Virus Gene Therapy Market Size by Type (M USD)
Table 27. Global Adeno Associated Virus Gene Therapy Sales (K Units) by Type (2020-2025)
Table 28. Global Adeno Associated Virus Gene Therapy Sales Market Share by Type (2020-2025)
Table 29. Global Adeno Associated Virus Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Adeno Associated Virus Gene Therapy Market Size Share by Type (2020-2025)
Table 31. Global Adeno Associated Virus Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Adeno Associated Virus Gene Therapy Sales (K Units) by Application
Table 33. Global Adeno Associated Virus Gene Therapy Market Size by Application
Table 34. Global Adeno Associated Virus Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 35. Global Adeno Associated Virus Gene Therapy Sales Market Share by Application (2020-2025)
Table 36. Global Adeno Associated Virus Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Adeno Associated Virus Gene Therapy Market Share by Application (2020-2025)
Table 38. Global Adeno Associated Virus Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Adeno Associated Virus Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 40. Global Adeno Associated Virus Gene Therapy Sales Market Share by Region (2020-2025)
Table 41. Global Adeno Associated Virus Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Adeno Associated Virus Gene Therapy Market Size Market Share by Region (2020-2025)
Table 43. North America Adeno Associated Virus Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 44. North America Adeno Associated Virus Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Adeno Associated Virus Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Adeno Associated Virus Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Adeno Associated Virus Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Adeno Associated Virus Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Adeno Associated Virus Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 50. South America Adeno Associated Virus Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Adeno Associated Virus Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Adeno Associated Virus Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Adeno Associated Virus Gene Therapy Production (K Units) by Region(2020-2025)
Table 54. Global Adeno Associated Virus Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Adeno Associated Virus Gene Therapy Revenue Market Share by Region (2020-2025)
Table 56. Global Adeno Associated Virus Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Adeno Associated Virus Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Adeno Associated Virus Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Adeno Associated Virus Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Adeno Associated Virus Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Creative Biolabs Basic Information
Table 62. Creative Biolabs Adeno Associated Virus Gene Therapy Product Overview
Table 63. Creative Biolabs Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Creative Biolabs Business Overview
Table 65. Creative Biolabs SWOT Analysis
Table 66. Creative Biolabs Recent Developments
Table 67. Affinia Therapeutics Basic Information
Table 68. Affinia Therapeutics Adeno Associated Virus Gene Therapy Product Overview
Table 69. Affinia Therapeutics Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Affinia Therapeutics Business Overview
Table 71. Affinia Therapeutics SWOT Analysis
Table 72. Affinia Therapeutics Recent Developments
Table 73. Spark Therapeutics Basic Information
Table 74. Spark Therapeutics Adeno Associated Virus Gene Therapy Product Overview
Table 75. Spark Therapeutics Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Spark Therapeutics Business Overview
Table 77. Spark Therapeutics SWOT Analysis
Table 78. Spark Therapeutics Recent Developments
Table 79. AGC Biologics Basic Information
Table 80. AGC Biologics Adeno Associated Virus Gene Therapy Product Overview
Table 81. AGC Biologics Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. AGC Biologics Business Overview
Table 83. AGC Biologics Recent Developments
Table 84. StrideBio Basic Information
Table 85. StrideBio Adeno Associated Virus Gene Therapy Product Overview
Table 86. StrideBio Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. StrideBio Business Overview
Table 88. StrideBio Recent Developments
Table 89. SIRION Biotech Basic Information
Table 90. SIRION Biotech Adeno Associated Virus Gene Therapy Product Overview
Table 91. SIRION Biotech Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. SIRION Biotech Business Overview
Table 93. SIRION Biotech Recent Developments
Table 94. Neurophth Biotechnology Basic Information
Table 95. Neurophth Biotechnology Adeno Associated Virus Gene Therapy Product Overview
Table 96. Neurophth Biotechnology Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Neurophth Biotechnology Business Overview
Table 98. Neurophth Biotechnology Recent Developments
Table 99. Belief BioMed Basic Information
Table 100. Belief BioMed Adeno Associated Virus Gene Therapy Product Overview
Table 101. Belief BioMed Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Belief BioMed Business Overview
Table 103. Belief BioMed Recent Developments
Table 104. BiBo Biopharma Engineering Co., Ltd. Basic Information
Table 105. BiBo Biopharma Engineering Co., Ltd. Adeno Associated Virus Gene Therapy Product Overview
Table 106. BiBo Biopharma Engineering Co., Ltd. Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. BiBo Biopharma Engineering Co., Ltd. Business Overview
Table 108. BiBo Biopharma Engineering Co., Ltd. Recent Developments
Table 109. Beihai Kangcheng Basic Information
Table 110. Beihai Kangcheng Adeno Associated Virus Gene Therapy Product Overview
Table 111. Beihai Kangcheng Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Beihai Kangcheng Business Overview
Table 113. Beihai Kangcheng Recent Developments
Table 114. PackGene Biotech Basic Information
Table 115. PackGene Biotech Adeno Associated Virus Gene Therapy Product Overview
Table 116. PackGene Biotech Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. PackGene Biotech Business Overview
Table 118. PackGene Biotech Recent Developments
Table 119. Sarepta Therapeutics Basic Information
Table 120. Sarepta Therapeutics Adeno Associated Virus Gene Therapy Product Overview
Table 121. Sarepta Therapeutics Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Sarepta Therapeutics Business Overview
Table 123. Sarepta Therapeutics Recent Developments
Table 124. Carbon BioSciences Basic Information
Table 125. Carbon BioSciences Adeno Associated Virus Gene Therapy Product Overview
Table 126. Carbon BioSciences Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Carbon BioSciences Business Overview
Table 128. Carbon BioSciences Recent Developments
Table 129. Kelonia Therapeutics Basic Information
Table 130. Kelonia Therapeutics Adeno Associated Virus Gene Therapy Product Overview
Table 131. Kelonia Therapeutics Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Kelonia Therapeutics Business Overview
Table 133. Kelonia Therapeutics Recent Developments
Table 134. Roche Basic Information
Table 135. Roche Adeno Associated Virus Gene Therapy Product Overview
Table 136. Roche Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Roche Business Overview
Table 138. Roche Recent Developments
Table 139. Remedium Bio Basic Information
Table 140. Remedium Bio Adeno Associated Virus Gene Therapy Product Overview
Table 141. Remedium Bio Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Remedium Bio Business Overview
Table 143. Remedium Bio Recent Developments
Table 144. Global Adeno Associated Virus Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 145. Global Adeno Associated Virus Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 146. North America Adeno Associated Virus Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 147. North America Adeno Associated Virus Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 148. Europe Adeno Associated Virus Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 149. Europe Adeno Associated Virus Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Asia Pacific Adeno Associated Virus Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 151. Asia Pacific Adeno Associated Virus Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America Adeno Associated Virus Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 153. South America Adeno Associated Virus Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Middle East and Africa Adeno Associated Virus Gene Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 155. Middle East and Africa Adeno Associated Virus Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 156. Global Adeno Associated Virus Gene Therapy Sales Forecast by Type (2026-2033) & (K Units)
Table 157. Global Adeno Associated Virus Gene Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 158. Global Adeno Associated Virus Gene Therapy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 159. Global Adeno Associated Virus Gene Therapy Sales (K Units) Forecast by Application (2026-2033)
Table 160. Global Adeno Associated Virus Gene Therapy Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Adeno Associated Virus Gene Therapy Market Size Comparison by Region (M USD)
Table 5. Global Adeno Associated Virus Gene Therapy Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Adeno Associated Virus Gene Therapy Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Adeno Associated Virus Gene Therapy Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Adeno Associated Virus Gene Therapy Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adeno Associated Virus Gene Therapy as of 2024)
Table 10. Global Market Adeno Associated Virus Gene Therapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Adeno Associated Virus Gene Therapy Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Adeno Associated Virus Gene Therapy Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Adeno Associated Virus Gene Therapy Sales by Type (K Units)
Table 26. Global Adeno Associated Virus Gene Therapy Market Size by Type (M USD)
Table 27. Global Adeno Associated Virus Gene Therapy Sales (K Units) by Type (2020-2025)
Table 28. Global Adeno Associated Virus Gene Therapy Sales Market Share by Type (2020-2025)
Table 29. Global Adeno Associated Virus Gene Therapy Market Size (M USD) by Type (2020-2025)
Table 30. Global Adeno Associated Virus Gene Therapy Market Size Share by Type (2020-2025)
Table 31. Global Adeno Associated Virus Gene Therapy Price (USD/Unit) by Type (2020-2025)
Table 32. Global Adeno Associated Virus Gene Therapy Sales (K Units) by Application
Table 33. Global Adeno Associated Virus Gene Therapy Market Size by Application
Table 34. Global Adeno Associated Virus Gene Therapy Sales by Application (2020-2025) & (K Units)
Table 35. Global Adeno Associated Virus Gene Therapy Sales Market Share by Application (2020-2025)
Table 36. Global Adeno Associated Virus Gene Therapy Market Size by Application (2020-2025) & (M USD)
Table 37. Global Adeno Associated Virus Gene Therapy Market Share by Application (2020-2025)
Table 38. Global Adeno Associated Virus Gene Therapy Sales Growth Rate by Application (2020-2025)
Table 39. Global Adeno Associated Virus Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 40. Global Adeno Associated Virus Gene Therapy Sales Market Share by Region (2020-2025)
Table 41. Global Adeno Associated Virus Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 42. Global Adeno Associated Virus Gene Therapy Market Size Market Share by Region (2020-2025)
Table 43. North America Adeno Associated Virus Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 44. North America Adeno Associated Virus Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Adeno Associated Virus Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 46. Europe Adeno Associated Virus Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Adeno Associated Virus Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 48. Asia Pacific Adeno Associated Virus Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 49. South America Adeno Associated Virus Gene Therapy Sales by Country (2020-2025) & (K Units)
Table 50. South America Adeno Associated Virus Gene Therapy Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Adeno Associated Virus Gene Therapy Sales by Region (2020-2025) & (K Units)
Table 52. Middle East and Africa Adeno Associated Virus Gene Therapy Market Size by Region (2020-2025) & (M USD)
Table 53. Global Adeno Associated Virus Gene Therapy Production (K Units) by Region(2020-2025)
Table 54. Global Adeno Associated Virus Gene Therapy Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Adeno Associated Virus Gene Therapy Revenue Market Share by Region (2020-2025)
Table 56. Global Adeno Associated Virus Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. North America Adeno Associated Virus Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Europe Adeno Associated Virus Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. Japan Adeno Associated Virus Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. China Adeno Associated Virus Gene Therapy Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 61. Creative Biolabs Basic Information
Table 62. Creative Biolabs Adeno Associated Virus Gene Therapy Product Overview
Table 63. Creative Biolabs Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 64. Creative Biolabs Business Overview
Table 65. Creative Biolabs SWOT Analysis
Table 66. Creative Biolabs Recent Developments
Table 67. Affinia Therapeutics Basic Information
Table 68. Affinia Therapeutics Adeno Associated Virus Gene Therapy Product Overview
Table 69. Affinia Therapeutics Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 70. Affinia Therapeutics Business Overview
Table 71. Affinia Therapeutics SWOT Analysis
Table 72. Affinia Therapeutics Recent Developments
Table 73. Spark Therapeutics Basic Information
Table 74. Spark Therapeutics Adeno Associated Virus Gene Therapy Product Overview
Table 75. Spark Therapeutics Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 76. Spark Therapeutics Business Overview
Table 77. Spark Therapeutics SWOT Analysis
Table 78. Spark Therapeutics Recent Developments
Table 79. AGC Biologics Basic Information
Table 80. AGC Biologics Adeno Associated Virus Gene Therapy Product Overview
Table 81. AGC Biologics Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 82. AGC Biologics Business Overview
Table 83. AGC Biologics Recent Developments
Table 84. StrideBio Basic Information
Table 85. StrideBio Adeno Associated Virus Gene Therapy Product Overview
Table 86. StrideBio Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 87. StrideBio Business Overview
Table 88. StrideBio Recent Developments
Table 89. SIRION Biotech Basic Information
Table 90. SIRION Biotech Adeno Associated Virus Gene Therapy Product Overview
Table 91. SIRION Biotech Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 92. SIRION Biotech Business Overview
Table 93. SIRION Biotech Recent Developments
Table 94. Neurophth Biotechnology Basic Information
Table 95. Neurophth Biotechnology Adeno Associated Virus Gene Therapy Product Overview
Table 96. Neurophth Biotechnology Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 97. Neurophth Biotechnology Business Overview
Table 98. Neurophth Biotechnology Recent Developments
Table 99. Belief BioMed Basic Information
Table 100. Belief BioMed Adeno Associated Virus Gene Therapy Product Overview
Table 101. Belief BioMed Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 102. Belief BioMed Business Overview
Table 103. Belief BioMed Recent Developments
Table 104. BiBo Biopharma Engineering Co., Ltd. Basic Information
Table 105. BiBo Biopharma Engineering Co., Ltd. Adeno Associated Virus Gene Therapy Product Overview
Table 106. BiBo Biopharma Engineering Co., Ltd. Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 107. BiBo Biopharma Engineering Co., Ltd. Business Overview
Table 108. BiBo Biopharma Engineering Co., Ltd. Recent Developments
Table 109. Beihai Kangcheng Basic Information
Table 110. Beihai Kangcheng Adeno Associated Virus Gene Therapy Product Overview
Table 111. Beihai Kangcheng Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 112. Beihai Kangcheng Business Overview
Table 113. Beihai Kangcheng Recent Developments
Table 114. PackGene Biotech Basic Information
Table 115. PackGene Biotech Adeno Associated Virus Gene Therapy Product Overview
Table 116. PackGene Biotech Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 117. PackGene Biotech Business Overview
Table 118. PackGene Biotech Recent Developments
Table 119. Sarepta Therapeutics Basic Information
Table 120. Sarepta Therapeutics Adeno Associated Virus Gene Therapy Product Overview
Table 121. Sarepta Therapeutics Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 122. Sarepta Therapeutics Business Overview
Table 123. Sarepta Therapeutics Recent Developments
Table 124. Carbon BioSciences Basic Information
Table 125. Carbon BioSciences Adeno Associated Virus Gene Therapy Product Overview
Table 126. Carbon BioSciences Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 127. Carbon BioSciences Business Overview
Table 128. Carbon BioSciences Recent Developments
Table 129. Kelonia Therapeutics Basic Information
Table 130. Kelonia Therapeutics Adeno Associated Virus Gene Therapy Product Overview
Table 131. Kelonia Therapeutics Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 132. Kelonia Therapeutics Business Overview
Table 133. Kelonia Therapeutics Recent Developments
Table 134. Roche Basic Information
Table 135. Roche Adeno Associated Virus Gene Therapy Product Overview
Table 136. Roche Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 137. Roche Business Overview
Table 138. Roche Recent Developments
Table 139. Remedium Bio Basic Information
Table 140. Remedium Bio Adeno Associated Virus Gene Therapy Product Overview
Table 141. Remedium Bio Adeno Associated Virus Gene Therapy Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 142. Remedium Bio Business Overview
Table 143. Remedium Bio Recent Developments
Table 144. Global Adeno Associated Virus Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 145. Global Adeno Associated Virus Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 146. North America Adeno Associated Virus Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 147. North America Adeno Associated Virus Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 148. Europe Adeno Associated Virus Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 149. Europe Adeno Associated Virus Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 150. Asia Pacific Adeno Associated Virus Gene Therapy Sales Forecast by Region (2026-2033) & (K Units)
Table 151. Asia Pacific Adeno Associated Virus Gene Therapy Market Size Forecast by Region (2026-2033) & (M USD)
Table 152. South America Adeno Associated Virus Gene Therapy Sales Forecast by Country (2026-2033) & (K Units)
Table 153. South America Adeno Associated Virus Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 154. Middle East and Africa Adeno Associated Virus Gene Therapy Sales Forecast by Country (2026-2033) & (Units)
Table 155. Middle East and Africa Adeno Associated Virus Gene Therapy Market Size Forecast by Country (2026-2033) & (M USD)
Table 156. Global Adeno Associated Virus Gene Therapy Sales Forecast by Type (2026-2033) & (K Units)
Table 157. Global Adeno Associated Virus Gene Therapy Market Size Forecast by Type (2026-2033) & (M USD)
Table 158. Global Adeno Associated Virus Gene Therapy Price Forecast by Type (2026-2033) & (USD/Unit)
Table 159. Global Adeno Associated Virus Gene Therapy Sales (K Units) Forecast by Application (2026-2033)
Table 160. Global Adeno Associated Virus Gene Therapy Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Adeno Associated Virus Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adeno Associated Virus Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Adeno Associated Virus Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Adeno Associated Virus Gene Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Adeno Associated Virus Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Adeno Associated Virus Gene Therapy Product Life Cycle
Figure 13. Adeno Associated Virus Gene Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Adeno Associated Virus Gene Therapy Revenue Share by Manufacturers in 2024
Figure 15. Adeno Associated Virus Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Adeno Associated Virus Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Adeno Associated Virus Gene Therapy Revenue in 2024
Figure 18. Industry Chain Map of Adeno Associated Virus Gene Therapy
Figure 19. Global Adeno Associated Virus Gene Therapy Market PEST Analysis
Figure 20. Global Adeno Associated Virus Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Adeno Associated Virus Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Adeno Associated Virus Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Adeno Associated Virus Gene Therapy by Type in 2024
Figure 29. Market Size Share of Adeno Associated Virus Gene Therapy by Type (2020-2025)
Figure 30. Market Size Share of Adeno Associated Virus Gene Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Adeno Associated Virus Gene Therapy Market Share by Application
Figure 33. Global Adeno Associated Virus Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Adeno Associated Virus Gene Therapy Sales Market Share by Application in 2024
Figure 35. Global Adeno Associated Virus Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Adeno Associated Virus Gene Therapy Market Share by Application in 2024
Figure 37. Global Adeno Associated Virus Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Adeno Associated Virus Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Adeno Associated Virus Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Adeno Associated Virus Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Adeno Associated Virus Gene Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Adeno Associated Virus Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Adeno Associated Virus Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Adeno Associated Virus Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Adeno Associated Virus Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Adeno Associated Virus Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Adeno Associated Virus Gene Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Adeno Associated Virus Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Adeno Associated Virus Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Adeno Associated Virus Gene Therapy Market Size Market Share by Region in 2024
Figure 68. China Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Adeno Associated Virus Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Adeno Associated Virus Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Adeno Associated Virus Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Adeno Associated Virus Gene Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Adeno Associated Virus Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Adeno Associated Virus Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Adeno Associated Virus Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Adeno Associated Virus Gene Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Adeno Associated Virus Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Adeno Associated Virus Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Adeno Associated Virus Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Adeno Associated Virus Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Adeno Associated Virus Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Adeno Associated Virus Gene Therapy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Adeno Associated Virus Gene Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Adeno Associated Virus Gene Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Adeno Associated Virus Gene Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Adeno Associated Virus Gene Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Adeno Associated Virus Gene Therapy Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Adeno Associated Virus Gene Therapy
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Adeno Associated Virus Gene Therapy Market Size (M USD), 2024-2033
Figure 5. Global Adeno Associated Virus Gene Therapy Market Size (M USD) (2020-2033)
Figure 6. Global Adeno Associated Virus Gene Therapy Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Adeno Associated Virus Gene Therapy Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Adeno Associated Virus Gene Therapy Product Life Cycle
Figure 13. Adeno Associated Virus Gene Therapy Sales Share by Manufacturers in 2024
Figure 14. Global Adeno Associated Virus Gene Therapy Revenue Share by Manufacturers in 2024
Figure 15. Adeno Associated Virus Gene Therapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Adeno Associated Virus Gene Therapy Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Adeno Associated Virus Gene Therapy Revenue in 2024
Figure 18. Industry Chain Map of Adeno Associated Virus Gene Therapy
Figure 19. Global Adeno Associated Virus Gene Therapy Market PEST Analysis
Figure 20. Global Adeno Associated Virus Gene Therapy Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Adeno Associated Virus Gene Therapy Market Share by Type
Figure 27. Sales Market Share of Adeno Associated Virus Gene Therapy by Type (2020-2025)
Figure 28. Sales Market Share of Adeno Associated Virus Gene Therapy by Type in 2024
Figure 29. Market Size Share of Adeno Associated Virus Gene Therapy by Type (2020-2025)
Figure 30. Market Size Share of Adeno Associated Virus Gene Therapy by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Adeno Associated Virus Gene Therapy Market Share by Application
Figure 33. Global Adeno Associated Virus Gene Therapy Sales Market Share by Application (2020-2025)
Figure 34. Global Adeno Associated Virus Gene Therapy Sales Market Share by Application in 2024
Figure 35. Global Adeno Associated Virus Gene Therapy Market Share by Application (2020-2025)
Figure 36. Global Adeno Associated Virus Gene Therapy Market Share by Application in 2024
Figure 37. Global Adeno Associated Virus Gene Therapy Sales Growth Rate by Application (2020-2025)
Figure 38. Global Adeno Associated Virus Gene Therapy Sales Market Share by Region (2020-2025)
Figure 39. Global Adeno Associated Virus Gene Therapy Market Size Market Share by Region (2020-2025)
Figure 40. North America Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Adeno Associated Virus Gene Therapy Sales Market Share by Country in 2024
Figure 43. North America Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Adeno Associated Virus Gene Therapy Market Size Market Share by Country in 2024
Figure 45. U.S. Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Adeno Associated Virus Gene Therapy Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Adeno Associated Virus Gene Therapy Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Adeno Associated Virus Gene Therapy Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Adeno Associated Virus Gene Therapy Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Adeno Associated Virus Gene Therapy Sales Market Share by Country in 2024
Figure 53. Europe Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Adeno Associated Virus Gene Therapy Market Size Market Share by Country in 2024
Figure 55. Germany Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Adeno Associated Virus Gene Therapy Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Adeno Associated Virus Gene Therapy Sales Market Share by Region in 2024
Figure 67. Asia Pacific Adeno Associated Virus Gene Therapy Market Size Market Share by Region in 2024
Figure 68. China Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Adeno Associated Virus Gene Therapy Sales and Growth Rate (K Units)
Figure 79. South America Adeno Associated Virus Gene Therapy Sales Market Share by Country in 2024
Figure 80. South America Adeno Associated Virus Gene Therapy Market Size and Growth Rate (M USD)
Figure 81. South America Adeno Associated Virus Gene Therapy Market Size Market Share by Country in 2024
Figure 82. Brazil Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Adeno Associated Virus Gene Therapy Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Adeno Associated Virus Gene Therapy Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Adeno Associated Virus Gene Therapy Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Adeno Associated Virus Gene Therapy Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Adeno Associated Virus Gene Therapy Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Adeno Associated Virus Gene Therapy Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Adeno Associated Virus Gene Therapy Production Market Share by Region (2020-2025)
Figure 103. North America Adeno Associated Virus Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Adeno Associated Virus Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Adeno Associated Virus Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 106. China Adeno Associated Virus Gene Therapy Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Adeno Associated Virus Gene Therapy Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Adeno Associated Virus Gene Therapy Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Adeno Associated Virus Gene Therapy Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Adeno Associated Virus Gene Therapy Market Share Forecast by Type (2026-2033)
Figure 111. Global Adeno Associated Virus Gene Therapy Sales Forecast by Application (2026-2033)
Figure 112. Global Adeno Associated Virus Gene Therapy Market Share Forecast by Application (2026-2033)
